- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03023215
Brief Guided Relaxation for Women Undergoing Stereotactic Breast Biopsy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Baseline Data Collection:
If participant chooses to take part in this study, they will be asked to fill out several questionnaires on an MD Anderson computer. Participant will be asked questions about anxiety, pain, and spirituality. The questionnaires will take about 20 minutes to complete.
Participant will have their heart rate and blood pressure taken, which will take about 3 minutes to complete. Participant will then have an electroencephalogram (EEG) done. An EEG is used to view a person's brain waves. The EEG should take about 5 minutes to complete. During the EEG, a snug cap which contains small electrodes will be placed on the head to measure the electrical patterns coming from the brain--much like the way a doctor listens to participant's heart from the surface of their skin. The EEG cap will stay on participant's head until the end of the study.
Study Groups:
After the baseline information is collected, participant will be randomly assigned (as in the role of a die) to 1 of 3 study groups: 2 relaxation training groups or a standard care group. Based on the way the study is designed, there is a 1 in 5 (or 20%) chance that participant will be assigned to the standard care group, and a 4 in 5 (or 80%) chance that participant will be assigned to one of the relaxation groups. Both relaxation groups will focus on helping participant to relax by focusing on their breath. At the end of participation, all groups will be given a 25 minute relaxation audio CD created by the MD Anderson Integrative Medicine Program.
Pre-Breast Biopsy Procedures:
Participants assigned to the relaxation groups will be guided through relaxation techniques for 10 minutes before the biopsy. Participants assigned to the third group will listen to 10 minutes of National Public Radio.
Participant's heart rate and EEG activity will be recorded during this 10-minute period of time. At the end of the 10-minute period before the breast biopsy, participant's blood pressure will be taken again and they will complete a 5 minute questionnaire about anxiety.
Breast Biopsy Procedures:
When it is time for the biopsy procedure, the research assistant will go with participant to their procedure room. In the procedure room, the research assistant will continue to monitor participant's heart rate and EEG activity throughout the biopsy time. If participant is in one of the relaxation groups, the relaxation guide will also accompany participant to the procedure room and will continue to be guided through relaxation during the biopsy procedure. If participant is in the standard care group, they will be provided with the usual breast biopsy care. Participant will be asked to talk about any anxiety and pain at several times during the procedure. Participant will also be asked to rest with their eyes closed during the biopsy procedure.
After the biopsy is finished, the research assistant will go with participant to a separate room, and they will have 5 minutes of EEG activity recorded, and their blood pressure will be taken. The EEG cap will then be removed, and participant will be asked to complete a questionnaire about their experience that will take less than 10 minutes to complete.
This is an investigational study.
Up to 85 participants will take part in this study. All will be enrolled at MD Anderson.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- University of Texas MD Anderson Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Women must have the ability to understand and read English, sign a written informed consent, and be willing to follow protocol requirements.
- Women must be right hand dominant.
- Women must be 18 years or older.
Exclusion Criteria:
- Women who have a documented diagnosis of a formal thought disorder (e.g., schizophrenia) will be excluded from the study.
- Women with a score of 3 or below on the Six-Item Cognitive Screener.
- Women who plan to take benzodiazepine (e.g, alprazolam, diazepam, clonazepam, lorazepam) or beta-blocker (e.g., propranolol, atenolol) on the day of their SBB.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Guided Meditation Group (GM)
Participants guided through 10 minutes of intervention by a mind-body specialist who will follow a standardized script prior to stereotactic breast biopsy (SBB). Mind-body specialist will also accompany participant during SBB to continue intervention. Electroencephalogram (EEG) activity and heart rate (HR) recorded at baseline, for 10 minutes prior to the SBB, throughout the SBB, and immediately following SBB. Self-report measures (anxiety and pain) assessed at baseline, immediately before, during, and after the SBB. |
Participants guided through 10 minutes of intervention by a mind-body specialist who will follow a standardized script prior to stereotactic breast biopsy (SBB).
Mind-body specialist will also accompany participant during SBB to continue intervention.
Electroencephalogram (EEG) activity recorded at baseline, for 10 minutes prior to the SBB, throughout the SBB, and immediately following SBB.
Other Names:
Self-report measures (anxiety and pain) assessed at baseline, immediately before, during, and after the SBB.
Other Names:
Heart rate (HR) recorded at baseline, for 10 minutes prior to the SBB, throughout the SBB, and immediately following SBB.
Other Names:
|
Active Comparator: Focused Breathing Group (FB)
Participants guided through 10 minutes of intervention by a mind-body specialist who will follow a standardized script prior to stereotactic breast biopsy (SBB). Mind-body specialist will also accompany participant during SBB to continue intervention. Electroencephalogram (EEG) activity and heart rate (HR) recorded at baseline, for 10 minutes prior to the SBB, throughout the SBB, and immediately following SBB. Self-report measures (anxiety and pain) assessed at baseline, immediately before, during, and after the SBB.. |
Participants guided through 10 minutes of intervention by a mind-body specialist who will follow a standardized script prior to stereotactic breast biopsy (SBB).
Mind-body specialist will also accompany participant during SBB to continue intervention.
Electroencephalogram (EEG) activity recorded at baseline, for 10 minutes prior to the SBB, throughout the SBB, and immediately following SBB.
Other Names:
Self-report measures (anxiety and pain) assessed at baseline, immediately before, during, and after the SBB.
Other Names:
Heart rate (HR) recorded at baseline, for 10 minutes prior to the SBB, throughout the SBB, and immediately following SBB.
Other Names:
|
Active Comparator: Standard of Care Group (SC)
Participants listen to a 10 minute neutral-content audio clip from National Public Radio prior to stereotactic breast biopsy (SBB). Electroencephalogram (EEG) activity and heart rate (HR) recorded at baseline, for 10 minutes prior to the SBB, throughout the SBB, and immediately following SBB. Self-report measures (anxiety and pain) assessed at baseline, immediately before, during, and after the SBB. |
Electroencephalogram (EEG) activity recorded at baseline, for 10 minutes prior to the SBB, throughout the SBB, and immediately following SBB.
Other Names:
Self-report measures (anxiety and pain) assessed at baseline, immediately before, during, and after the SBB.
Other Names:
Heart rate (HR) recorded at baseline, for 10 minutes prior to the SBB, throughout the SBB, and immediately following SBB.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Participation and Completion Rate of Incorporating a Guided Meditation Program in Participants Undergoing Stereotactic Breast Biopsy (SBB)
Time Frame: 1 day
|
Trial considered successful if over 50% of eligible patients participate and at least 80% of the consented patients complete the sessions and all the measures for the study.
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of GM Compared to Focused Breathing (FB) and Standard Care (SC) Control Groups on Self-Reported Anxiety in Participants Undergoing SBB
Time Frame: 3-5 minute intervals throughout the SBB procedure
|
Participants provide a rating from 0-10, with a rating of 0 indicating ''no anxiety'' and 10 indicating ''worst possible anxiety'' at 3-5 minute intervals throughout the SBB procedure.
|
3-5 minute intervals throughout the SBB procedure
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Lorenzo Cohen, PHD, M.D. Anderson Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2011-1094
- NCI-2017-00506 (Other Identifier: NCI CTRP)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Meditation for Breast Biopsy
-
Mayo ClinicCompletedSuspicious Breast Lesion for Which Biopsy is ScheduledUnited States
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; CGenetixNot yet recruitingKidney Transplant Patients Eligible for a Solid Biopsy
-
Washington University School of MedicineNational Cancer Institute (NCI)RecruitingBreast BiopsyUnited States
-
University of Alabama at BirminghamCompletedBreast BiopsyUnited States
-
Unità di Medicina della Riproduzione, ItalyCompletedIncrease the Number of Blastocyst to Biopsy for Preimplantation Genetic TestingItaly
-
Duke UniversityCompleted
-
University Hospital, Clermont-FerrandCompletedNon-obstructive Azoospermia With Testicular Biopsy for Spermatozoa ExtractionFrance
-
TriHealth Inc.WithdrawnPain Management After Breast BiopsyUnited States
-
Hospital Universitario 12 de OctubreCompleted
Clinical Trials on Meditation
-
University of California, San FranciscoCompleted
-
M.D. Anderson Cancer CenterCompleted
-
Consuelo Lourdes Díaz RodríguezCompleted
-
Beth Israel Deaconess Medical CenterCompletedKnee Osteoarthritis | Osteo Arthritis Knee | Knee Injuries | Osteonecrosis | Opioid Use Disorder | Opioid Dependence | Arthropathy of Knee | Opioid Use | Meditation | Knee DiseaseUnited States
-
St. Louis UniversityCompletedStress | Premature Birth | Depression, Postpartum | Anxiety | Breast Feeding | Self Efficacy | Behavior, Maternal | Insufficient LactationUnited States
-
Centre Francois BaclesseRecruitingPatients With CancerFrance
-
Federal University of Minas GeraisHarvard Medical School (HMS and HSDM)Active, not recruitingDepressive Disorder | Quality of Life | Sleep Disorder | Anxiety Disorders | Insomnia | Spirituality | Stress Disorder | Insomnia Chronic | Insomnia Disorder | Complementary TherapyBrazil
-
Johns Hopkins UniversityUniversity of California, San Diego; University of Maryland, Baltimore; National... and other collaboratorsCompleted